Person profile

Public information reviewed

Srinivas Akkaraju, M.D., Ph.D.

Board role

Director · Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

Board role

Director · ALUMIS INC. (NASDAQ: ALMS)

Board role

Director · vTv Therapeutics Inc. (NASDAQ: VTVT)

Board role

Director · Scholar Rock Holding Corp (NASDAQ: SRRK)

Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

Director · Current mandate

Director · Executive · Board
FollowSave PDF
More
Reports & analysis (Check report directory)Alpha Eval
Evidence records
13
Profile ownership
Not yet claimed
Record reviewed
May 15, 2026
View evidence

Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
44 current organizations shown on this profile
Board positions
44 supported by public sources, 0 supplied by the profile owner
Committee roles
3Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Dr. Akkaraju is a founder and managing member of Samsara BioCapital, a venture capital firm, since March 2017. He previously served as a general partner at Sofinnova Ventures and managing director at New Leaf Venture Partners. He holds an M.D. and Ph.D. in Immunology from Stanford University and serves on boards of multiple biopharmaceutical companies.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Kalaris Therapeutics, Inc.

2025-01-01 · current

Confirmed by public sourceView source

Director

vTv Therapeutics Inc.

2024-01-01 · current

Confirmed by public sourceView source

Director

ALUMIS INC.

2024-01-01 · current

Confirmed by public sourceView source

Director

Scholar Rock Holding Corp

2022-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

ALUMIS INC.

Open ALUMIS INC. profile →

Director at ALUMIS INC.

2024-01-01 → End not stated

current · source reported

Observed: 2026-09-25

ALUMIS INC.ALUMIS INC.Kalaris Therapeuti…Kalaris Therapeutics, Inc.Scholar Rock Holdi…Scholar Rock Holding CorpvTv Therapeutics I…vTv Therapeutics Inc.Srinivas Akkaraju,…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingKalaris Therapeutics, Inc. director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 2 · Sec FilingScholar Rock Holding director board sourceSupports Board membership, Committee assignments, Director since, Board independence.Open sourceSource 3 · Sec FilingALMS DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 4 · Sec ProxyPublic profile sourceSupports Director at vTv Therapeutics Inc. (NASDAQ: VTVT).Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:srinivas-akkaraju-m-d-ph-d
Record version
public-0

Published evidence records

13 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Kalaris Therapeutics, Inc. director board source

    sec filing · Source published: Apr 24, 2026 · Retrieved: May 3, 2026

    Supports 6 claims
    • Board independence: Not independent (executive director) · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of ALUMIS INC. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of vTv Therapeutics Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  2. KLRS DEF 14A director slate

    sec filing · Source published: Apr 24, 2026 · Retrieved: May 1, 2026

    Supports 4 claims
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Nominating/Governance · Claim reviewed: May 1, 2026
    • Executive company: Executive at Samsara BioCapital L.P. · Claim reviewed: May 1, 2026
    • Executive title: Executive title: Founder and Managing General Partner · Claim reviewed: May 1, 2026

  3. Open source

    sec proxy · Source published: Apr 24, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Kalaris Therapeutics, Inc. · Claim reviewed: May 15, 2026

  4. Scholar Rock Holding director board source

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 3, 2026

    Supports 6 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of ALUMIS INC. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of vTv Therapeutics Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  5. SRRK DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: Apr 29, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Nominating/Governance, Science/Innovation · Claim reviewed: Apr 29, 2026

  6. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 29, 2026

    Supports 1 claim
    • Professional Role: Director at Scholar Rock Holding Corp · Claim reviewed: May 15, 2026

  7. ALMS DEF 14A director slate

    sec filing · Source published: Jun 16, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  8. Open source

    sec proxy · Source published: Jun 16, 2025 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at ALUMIS INC. · Claim reviewed: May 15, 2026

  9. Open source

    sec proxy · Source published: Apr 25, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at vTv Therapeutics Inc. · Claim reviewed: May 15, 2026

  10. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Kalaris Therapeutics, Inc. · Claim reviewed: May 3, 2026

  11. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of vTv Therapeutics Inc. · Claim reviewed: May 3, 2026

  12. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ALUMIS INC. · Claim reviewed: May 3, 2026

  13. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Scholar Rock Holding · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board independence · Under reviewNot independent (executive director)1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Under reviewIndependent director1 source
Verification
Under review
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of ALUMIS INC.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Kalaris Therapeutics, Inc.Supported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Scholar Rock HoldingSupported by 4 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of vTv Therapeutics Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: DirectorSupported by 3 public records3 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Audit1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance, Science/Innovation1 source
Verification
Source reported
Confidence
88%
Last reviewed
Apr 29, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Samsara BioCapital L.P.1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Executive title · Source reportedExecutive title: Founder and Managing General Partner1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources13 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 1, 2026

    Supports: Board role · Committee assignments · Executive company · Executive title

  3. https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Kalaris Therapeutics, Inc. (NASDAQ: KLRS)

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed Apr 29, 2026

    Supports: Board role · Committee assignments

  6. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 29, 2026

    Supports: Director at Scholar Rock Holding Corp (NASDAQ: SRRK)

  7. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  8. https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at ALUMIS INC. (NASDAQ: ALMS)

  9. https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm

    Sec Proxy · Tier not stated · Reviewed Apr 28, 2026

    Supports: Director at vTv Therapeutics Inc. (NASDAQ: VTVT)

  10. https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  11. https://www.sec.gov/Archives/edgar/data/1641489/000164148925000024/vtvt-20250425.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  12. https://www.sec.gov/Archives/edgar/data/1847367/000110465925059837/tm2515405-1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  13. https://www.sec.gov/Archives/edgar/data/1727196/000110465926046917/tm261440-1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership